{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:43:41Z","timestamp":1782902621990,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bursa Uludag University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Age-related macular degeneration (AMD) is a multifactorial disease that leads to progressive central vision loss. Bevacizumab (Avastin), a therapeutic agent used in the treatment of AMD, exerts its effect by binding to all isoforms of vascular endothelial growth factor (VEGF), thereby inhibiting angiogenesis. This study aimed to investigate the effects of Bevacizumab on immune system cells in the context of neovascular AMD (nAMD) treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with nAMD receiving Bevacizumab treatment (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918) and a control group of individuals undergoing cataract surgery (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200919) were included in the study. Peripheral blood samples were collected from nAMD patients before Bevacizumab treatment (baseline, 0 month) and after three monthly intravitreal injections. Following staining with monoclonal antibodies, innate immune cell, T cell, and B cell subsets were analyzed using flow cytometry panels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the innate immune cell subsets of patients with neovascular AMD (nAMD), immature and suppressive neutrophils were significantly increased, whereas intermediate and non-classical monocytes were significantly decreased. Following intravitreal bevacizumab (IVB) treatment, these cell populations tended to return toward baseline levels. In the adaptive immune compartment, effector memory (EM) T cell subsets, particularly EM1 (effector memory 1) and EM3 (effector memory 3), exhibited opposing dynamics, showing significant changes both before and after IVB treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, the findings from this study provide preliminary evidence that various immune cell subsets in both innate and adaptive compartments show associations with AMD pathogenesis and with IVB treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00417-026-07350-w","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:45:35Z","timestamp":1782899135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of intravitreal bevacizumab on immune cells in neovascular age related macular degeneration"],"prefix":"10.1007","author":[{"given":"Ali Eren","family":"Iskin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Ali","family":"Kizmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Ka\u00e7maz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Ucan Gunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Baykara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-9148","authenticated-orcid":false,"given":"Ferah","family":"Budak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"6","key":"7350_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.22608\/APO.2017251","volume":"6","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Cheung CMG, Panda-Jonas S (2017) Updates on the epidemiology of age-related macular degeneration. Asia-Pacific J Ophthalmol (Philadelphia Pa) 6(6):493\u2013497. https:\/\/doi.org\/10.22608\/APO.2017251","journal-title":"Asia-Pacific J Ophthalmol (Philadelphia Pa)"},{"key":"7350_CR2","doi-asserted-by":"publisher","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet. Global Health 2(2):e106\u2013e116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","DOI":"10.1016\/S2214-109X(13)70145-1"},{"key":"7350_CR3","doi-asserted-by":"publisher","first-page":"1009599","DOI":"10.3389\/fnins.2022.1009599","volume":"16","author":"JHC Wong","year":"2022","unstructured":"Wong JHC, Ma JYW, Jobling AI, Brandli A, Greferath U, Fletcher EL, Vessey KA (2022) Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system. Front NeuroSci 16:1009599. https:\/\/doi.org\/10.3389\/fnins.2022.1009599","journal-title":"Front NeuroSci"},{"issue":"1","key":"7350_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY (2021) Age-related macular degeneration. Nat reviews Disease primers 7(1):31. https:\/\/doi.org\/10.1038\/s41572-021-00265-2","journal-title":"Nat reviews Disease primers"},{"issue":"4","key":"7350_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","volume":"27","author":"JS Penn","year":"2008","unstructured":"Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27(4):331\u2013371. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.05.001","journal-title":"Prog Retin Eye Res"},{"key":"7350_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.18553\/jmcp.2018.24.2-a.s3","volume":"24","author":"CC Wykoff","year":"2018","unstructured":"Wykoff CC, Clark WL, Nielsen JS, Brill JV, Greene LS, Heggen CL (2018) Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration. J managed care specialty Pharm 24:S3\u2013S15. 2-a Supplhttps:\/\/doi.org\/10.18553\/jmcp.2018.24.2-a.s3","journal-title":"J managed care specialty Pharm"},{"issue":"3","key":"7350_CR7","first-page":"353","volume":"58","author":"JZ Nowak","year":"2006","unstructured":"Nowak JZ (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58(3):353\u2013363","journal-title":"Pharmacol Rep"},{"issue":"10","key":"7350_CR8","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1002\/mco2.714","volume":"5","author":"R Wang","year":"2024","unstructured":"Wang R, Lan C, Benlagha K, Camara NOS, Miller H, Kubo M, Heegaard S, Lee P, Yang L, Forsman H, Li X, Zhai Z, Liu C (2024) The interaction of innate immune and adaptive immune system. MedComm 5(10):e714. https:\/\/doi.org\/10.1002\/mco2.714","journal-title":"MedComm"},{"issue":"4","key":"7350_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.bbrc.2013.05.120","volume":"438","author":"F Matsuki","year":"2013","unstructured":"Matsuki F, Saegusa J, Miyamoto Y, Misaki K, Kumagai S, Morinobu A (2013) CD45RA-Foxp3(high) activated\/effector regulatory T cells in the CCR7\u2009+\u2009CD45RA-CD27\u2009+\u2009CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis. Biochem Biophys Res Commun 438(4):778\u2013783. https:\/\/doi.org\/10.1016\/j.bbrc.2013.05.120","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"7350_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2174\/138920212803759749","volume":"13","author":"MA Moro-Garc\u00eda","year":"2012","unstructured":"Moro-Garc\u00eda MA, Alonso-Arias R, L\u00f3pez-Larrea C (2012) Molecular mechanisms involved in the aging of the T-cell immune response. Curr Genom 13(8):589\u2013602. https:\/\/doi.org\/10.2174\/138920212803759749","journal-title":"Curr Genom"},{"issue":"5","key":"7350_CR11","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s11357-012-9488-5","volume":"35","author":"S Buffa","year":"2013","unstructured":"Buffa S, Pellican\u00f2 M, Bulati M, Martorana A, Goldeck D, Caruso C, Pawelec G, Colonna-Romano G (2013) A novel B cell population revealed by a CD38\/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age (Dordrecht Netherlands) 35(5):2009\u20132024. https:\/\/doi.org\/10.1007\/s11357-012-9488-5","journal-title":"Age (Dordrecht Netherlands)"},{"issue":"3","key":"7350_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pan.2014.02.004","volume":"14","author":"K Sumimoto","year":"2014","unstructured":"Sumimoto K, Uchida K, Kusuda T, Mitsuyama T, Sakaguchi Y, Fukui T, Matsushita M, Takaoka M, Nishio A, Okazaki K (2014) The role of CD19\u2009+\u2009CD24high CD38high and CD19\u2009+\u2009CD24high CD27\u2009+\u2009regulatory B cells in patients with type 1 autoimmune pancreatitis. Pancreatology: official J Int Association Pancreatology (IAP) \u2026 et al ] 14(3):193\u2013200. https:\/\/doi.org\/10.1016\/j.pan.2014.02.004","journal-title":"Pancreatology: official J Int Association Pancreatology (IAP) \u2026 et al ]"},{"key":"7350_CR13","doi-asserted-by":"publisher","first-page":"822400","DOI":"10.3389\/fped.2022.822400","volume":"10","author":"F Corrente","year":"2022","unstructured":"Corrente F, Terreri S, Palomba P, Capponi C, Mirabella M, Perno CF, Carsetti R (2022) CD21-CD27- Atypical B cells in a pediatric cohort study: an extensive single center flow cytometric analysis. Front Pead 10:822400. https:\/\/doi.org\/10.3389\/fped.2022.822400","journal-title":"Front Pead"},{"issue":"1","key":"7350_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/IAE.0000000000003628","volume":"43","author":"YY Song","year":"2023","unstructured":"Song YY, Jun JH, Kim JT, Lee SC, Lee MW (2023) Character\u0131st\u0131cs of age-related macular degenerat\u0131on show\u0131ng a poor response to three load\u0131ng doses of ant\u0131-vascular endothel\u0131al growth factor. Retina (Philadelphia Pa) 43(1):8\u201315. https:\/\/doi.org\/10.1097\/IAE.0000000000003628","journal-title":"Retina (Philadelphia Pa)"},{"key":"7350_CR15","doi-asserted-by":"publisher","unstructured":"Kalina, T., Flores-Montero, J., van der Velden, V. H., Martin-Ayuso, M., B\u00f6ttcher,S., Ritgen, M., Almeida, J., Lhermitte, L., Asnafi, V., Mendon\u00e7a, A., de Tute, R.,Cullen, M., Sedek, L., Vidriales, M. B., P\u00e9rez, J. J., te Marvelde, J. G., Mejstrikova,E., Hrusak, O., Szczepa\u0144ski, T., van Dongen, J. J., \u2026 EuroFlow Consortium (EU-FP6,LSHB-CT-2006-018708) (2012). EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia, 26(9), 1986\u20132010. https:\/\/doi.org\/10.1038\/leu.2012.122","DOI":"10.1038\/leu.2012.122"},{"key":"7350_CR16","doi-asserted-by":"publisher","unstructured":"Kizmaz MA, Simsek A, Bozkurt T et al (2022) Effector memory T cell subset CD45RA-CCR7\u2010CD27\u2010CD28\u2010EM3 increases in direct proportion to the disease severity of COVID-19. Scand J Immunol Published online September 22. https:\/\/doi.org\/10.1111\/sji.13217","DOI":"10.1111\/sji.13217"},{"issue":"10","key":"7350_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/bjo.2007.116939","volume":"91","author":"A Lotery","year":"2007","unstructured":"Lotery A, Xu X, Zlatava G, Loftus J (2007) Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study. Br J Ophthalmol 91(10):1303\u20131307. https:\/\/doi.org\/10.1136\/bjo.2007.116939","journal-title":"Br J Ophthalmol"},{"key":"7350_CR18","doi-asserted-by":"publisher","first-page":"h1654","DOI":"10.1136\/bmj.h1654","volume":"350","author":"D Cohen","year":"2015","unstructured":"Cohen D (2015) Why have UK doctors been deterred from prescribing Avastin? BMJ 350:h1654. https:\/\/doi.org\/10.1136\/bmj.h1654","journal-title":"BMJ"},{"issue":"2","key":"7350_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00280-016-3079-6","volume":"78","author":"K Han","year":"2016","unstructured":"Han K, Peyret T, Marchand M, Quartino A, Gosselin NH, Girish S, Allison DE, Jin J (2016) Population pharmacokinetics of bevacizumab in cancer patients with external validation. Cancer Chemother Pharmacol 78(2):341\u2013351. https:\/\/doi.org\/10.1007\/s00280-016-3079-6","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"7350_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/bjo.2008.156810","volume":"94","author":"K Matsuyama","year":"2010","unstructured":"Matsuyama K, Ogata N, Matsuoka M, Wada M, Takahashi K, Nishimura T (2010) Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab. Br J Ophthalmol 94(9):1215\u20131218. https:\/\/doi.org\/10.1136\/bjo.2008.156810","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"7350_CR21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","volume":"114","author":"SJ Bakri","year":"2007","unstructured":"Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ (2007) Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114(5):855\u2013859. https:\/\/doi.org\/10.1016\/j.ophtha.2007.01.017","journal-title":"Ophthalmology"},{"issue":"5","key":"7350_CR22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.ophtha.2012.11.002","volume":"120","author":"A Singh","year":"2013","unstructured":"Singh A, Falk MK, Hviid TV, S\u00f8rensen TL (2013) Increased expression of CD200 on circulating CD11b+ monocytes in patients with neovascular age-related macular degeneration. Ophthalmology 120(5):1029\u20131037. https:\/\/doi.org\/10.1016\/j.ophtha.2012.11.002","journal-title":"Ophthalmology"},{"key":"7350_CR23","doi-asserted-by":"publisher","first-page":"16754","DOI":"10.1038\/srep16754","volume":"5","author":"J Lechner","year":"2015","unstructured":"Lechner J, Chen M, Hogg RE, Toth L, Silvestri G, Chakravarthy U, Xu H (2015) Alterations in circulating immune cells in neovascular age-related macular degeneration. Sci Rep 5:16754. https:\/\/doi.org\/10.1038\/srep16754","journal-title":"Sci Rep"},{"issue":"5","key":"7350_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/jamaophthalmol.2019.0010","volume":"137","author":"Y Subhi","year":"2019","unstructured":"Subhi Y, Nielsen K, Molbech M, Kr\u00fcger CR, Falk M, Singh A, Hviid TVF, Nissen MH, S\u00f8rensen TL (2019) Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. JAMA Ophthalmol 137(5):515\u2013522. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0010","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"7350_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/ceo.13152","volume":"46","author":"Y Subhi","year":"2018","unstructured":"Subhi Y, Krogh Nielsen M, Molbech CR, S\u00f8rensen TL (2018) Altered proportion of CCR2+ and CX3CR1+ circulating monocytes in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Clin Exp Ophthalmol 46(6):661\u2013669. https:\/\/doi.org\/10.1111\/ceo.13152","journal-title":"Clin Exp Ophthalmol"},{"key":"7350_CR26","doi-asserted-by":"publisher","first-page":"29046","DOI":"10.1038\/srep29046","volume":"6","author":"M Grunin","year":"2016","unstructured":"Grunin M, Hagbi-Levi S, Rinsky B, Smith Y, Chowers I (2016) Transcriptome analysis on monocytes from patients with neovascular age-related macular degeneration. Sci Rep 6:29046. https:\/\/doi.org\/10.1038\/srep29046","journal-title":"Sci Rep"},{"key":"7350_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-immunol-042617-053119","volume":"37","author":"PB Narasimhan","year":"2019","unstructured":"Narasimhan PB, Marcovecchio P, Hamers AAJ, Hedrick CC (2019) Nonclassical monocytes in health and disease. Annu Rev Immunol 37:439\u2013456. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053119","journal-title":"Annu Rev Immunol"},{"key":"7350_CR28","doi-asserted-by":"publisher","unstructured":"Kapellos TS, Bonaguro L, Gem\u00fcnd I, Reusch N, Saglam A, Hinkley ER, Schultze JL (2019) Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol 10:2035. https:\/\/doi.org\/10.3389\/fimmu.2019.02035","DOI":"10.3389\/fimmu.2019.02035"},{"key":"7350_CR29","doi-asserted-by":"publisher","first-page":"13886","DOI":"10.1038\/srep13886","volume":"5","author":"R Mukherjee","year":"2015","unstructured":"Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B (2015) Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous. Sci Rep 5:13886. https:\/\/doi.org\/10.1038\/srep13886","journal-title":"Sci Rep"},{"issue":"5","key":"7350_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1189\/jlb.0612273","volume":"92","author":"VM Kamp","year":"2012","unstructured":"Kamp VM, Pillay J, Lammers JW, Pickkers P, Ulfman LH, Koenderman L (2012) Human suppressive neutrophils CD16bright\/CD62Ldim exhibit decreased adhesion. J Leukoc Biol 92(5):1011\u20131020. https:\/\/doi.org\/10.1189\/jlb.0612273","journal-title":"J Leukoc Biol"},{"issue":"11","key":"7350_CR31","doi-asserted-by":"publisher","first-page":"120134","DOI":"10.1098\/rsob.120134","volume":"2","author":"M Beyrau","year":"2012","unstructured":"Beyrau M, Bodkin JV, Nourshargh S (2012) Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open biology 2(11):120134. https:\/\/doi.org\/10.1098\/rsob.120134","journal-title":"Open biology"},{"key":"7350_CR32","doi-asserted-by":"publisher","first-page":"1494831","DOI":"10.3389\/fsurg.2025.1494831","volume":"12","author":"EJ de Fraiture","year":"2025","unstructured":"de Fraiture EJ, Reniers T, Vreeman NEW, Rettig TCD, van Santvoort HC, Bikker A, Vrisekoop N, Koenderman L, Hietbrink F, Noordzij PG (2025) Neutrophil phenotypes quantify tissue damage caused by major surgery. Front Surg 12:1494831. https:\/\/doi.org\/10.3389\/fsurg.2025.1494831","journal-title":"Front Surg"},{"issue":"1","key":"7350_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000535541","volume":"16","author":"N Rong","year":"2024","unstructured":"Rong N, Wei X, Liu J (2024) The role of neutrophil in COVID-19: positive or negative. J Innate Immun 16(1):80\u201395. https:\/\/doi.org\/10.1159\/000535541","journal-title":"J Innate Immun"},{"issue":"1","key":"7350_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1164\/rccm.202104-1027OC","volume":"205","author":"A Meghraoui-Kheddar","year":"2022","unstructured":"Meghraoui-Kheddar A, Chousterman BG, Guillou N, Barone SM, Granjeaud S, Vallet H, Corneau A, Guessous K, de Roquetaillade C, Boissonnas A, Irish JM, Combadi\u00e8re C (2022) Two new neutrophil subsets define a discriminating sepsis signature. Am J Respir Crit Care Med 205(1):46\u201359. https:\/\/doi.org\/10.1164\/rccm.202104-1027OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"7350_CR35","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/art.41395","volume":"72","author":"SH Tay","year":"2020","unstructured":"Tay SH, Celhar T, Fairhurst AM (2020) Low-density neutrophils in systemic lupus erythematosus. Arthritis Rheumatol (Hoboken N J) 72(10):1587\u20131595. https:\/\/doi.org\/10.1002\/art.41395","journal-title":"Arthritis Rheumatol (Hoboken N J)"},{"issue":"4","key":"7350_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","volume":"10","author":"JY Sagiv","year":"2015","unstructured":"Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, Damti P, Lumbroso D, Polyansky L, Sionov RV, Ariel A, Hovav AH, Henke E, Fridlender ZG, Granot Z (2015) Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep 10(4):562\u2013573. https:\/\/doi.org\/10.1016\/j.celrep.2014.12.039","journal-title":"Cell Rep"},{"key":"7350_CR37","doi-asserted-by":"publisher","unstructured":"Marini, O., Costa, S., Bevilacqua, D., Calzetti, F., Tamassia, N., Spina, C., De Sabata,D., Tinazzi, E., Lunardi, C., Scupoli, M. T., Cavallini, C., Zoratti, E., Tinazzi,I., Marchetta, A., Vassanelli, A., Cantini, M., Gandini, G., Ruzzenente, A., Guglielmi,A., Missale, F., \u2026 Scapini, P. (2017). Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells.Blood, 129(10), 1343\u20131356. https:\/\/doi.org\/10.1182\/blood-2016-04-713206","DOI":"10.1182\/blood-2016-04-713206"},{"key":"7350_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejphar.2015.03.088","volume":"778","author":"G Marone","year":"2016","unstructured":"Marone G, Varricchi G, Loffredo S, Granata F (2016) Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis. Eur J Pharmacol 778:146\u2013151. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.088","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"7350_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1600-0420.2007.01067.x","volume":"86","author":"C Shima","year":"2008","unstructured":"Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y, Sawa M, Tsujikawa M, Kusaka S, Tano Y (2008) Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86(4):372\u2013376. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.01067.x","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"7350_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41598-017-00741-4","volume":"7","author":"A Singh","year":"2017","unstructured":"Singh A, Subhi Y, Krogh Nielsen M, Falk MK, Matzen SMH, Sellebjerg F, S\u00f8rensen TL (2017) Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study. Sci Rep 7(1):605. https:\/\/doi.org\/10.1038\/s41598-017-00741-4","journal-title":"Sci Rep"},{"key":"7350_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12886-016-0251-z","volume":"16","author":"Y Yu","year":"2016","unstructured":"Yu Y, Ren XR, Wen F, Chen H, Su SB (2016) T-helper-associated cytokines expression by peripheral blood mononuclear cells in patients with polypoidal choroidal vasculopathy and age-related macular degeneration. BMC Ophthalmol 16:80. https:\/\/doi.org\/10.1186\/s12886-016-0251-z","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"7350_CR42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/apm.12511","volume":"124","author":"JJ Chen","year":"2016","unstructured":"Chen JJ, Han BS, Xu SG, Vu H, Farrow JW, Rodman CL, Zhu Y, Wang WZ (2016) Hypersensitivity toward bacterial stimuli in patients with age-related macular degeneration. APMIS: acta pathologica Microbiol et Immunol Scand 124(5):406\u2013413. https:\/\/doi.org\/10.1111\/apm.12511","journal-title":"APMIS: acta pathologica Microbiol et Immunol Scand"},{"key":"7350_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4933-5-6","volume":"5","author":"S Koch","year":"2008","unstructured":"Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G (2008) Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun ageing: I A 5:6. https:\/\/doi.org\/10.1186\/1742-4933-5-6","journal-title":"Immun ageing: I A"},{"issue":"7","key":"7350_CR44","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.4049\/jimmunol.178.7.4112","volume":"178","author":"P Romero","year":"2007","unstructured":"Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser DE, Rufer N (2007) Four functionally distinct populations of human effector-memory CD8\u2009+\u2009T lymphocytes. J Immunol (Baltimore Md : 1950) 178(7):4112\u20134119. https:\/\/doi.org\/10.4049\/jimmunol.178.7.4112","journal-title":"J Immunol (Baltimore Md : 1950)"},{"key":"7350_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fimmu.2013.00107","volume":"4","author":"MA Moro-Garc\u00eda","year":"2013","unstructured":"Moro-Garc\u00eda MA, Alonso-Arias R, L\u00f3pez-Larrea C (2013) When aging reaches CD4\u2009+\u2009T-cells: phenotypic and functional changes. Front Immunol 4:107. https:\/\/doi.org\/10.3389\/fimmu.2013.00107","journal-title":"Front Immunol"},{"key":"7350_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13217","author":"MA Kizmaz","year":"2022","unstructured":"Kizmaz MA, Simsek A, Bozkurt T, Cagan E, Dombaz F, Tezcan G, Asan A, Demir H\u0130, Bal SH, Ermis Y, Coskun D, Yilmaz F, Akal\u0131n E, Oral EH, H. B., Budak F (2022) Effector memory T cell subset CD45RA-CCR7\u2010CD27\u2010CD28\u2010EM3 increases in direct proportion to the disease severity of COVID-19. Scand J Immunol. e13217. Advance online publication https:\/\/doi.org\/10.1111\/sji.13217","journal-title":"Scand J Immunol"},{"issue":"10","key":"7350_CR47","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.3390\/biomedicines11102778","volume":"11","author":"I Kudryavtsev","year":"2023","unstructured":"Kudryavtsev I, Benevolenskaya S, Serebriakova M, Grigor\u2019yeva I, Kuvardin E, Rubinstein A, Golovkin A, Kalinina O, Zaikova E, Lapin S, Maslyanskiy A (2023) Circulating CD8\u2009+\u2009T cell subsets in primary Sj\u00f6gren\u2019s syndrome. Biomedicines 11(10):2778. https:\/\/doi.org\/10.3390\/biomedicines11102778","journal-title":"Biomedicines"},{"issue":"3","key":"7350_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/cei\/uxac103","volume":"210","author":"I Gjertsson","year":"2022","unstructured":"Gjertsson I, McGrath S, Grimstad K, Jonsson CA, Camponeschi A, Thorarinsdottir K, M\u00e5rtensson IL (2022) A close-up on the expanding landscape of CD21-\/low B cells in humans. Clin Exp Immunol 210(3):217\u2013229. https:\/\/doi.org\/10.1093\/cei\/uxac103","journal-title":"Clin Exp Immunol"},{"key":"7350_CR49","doi-asserted-by":"publisher","first-page":"29699","DOI":"10.1038\/srep29699","volume":"6","author":"F Piancone","year":"2016","unstructured":"Piancone F, Saresella M, Marventano I, La Rosa F, Zoppis M, Agostini S, Longhi R, Caputo D, Mendozzi L, Rovaris M, Clerici M (2016) B lymphocytes in multiple sclerosis: bregs and BTLA\/CD272 Expressing-CD19\u2009+\u2009lymphocytes modulate disease severity. Sci Rep 6:29699. https:\/\/doi.org\/10.1038\/srep29699","journal-title":"Sci Rep"},{"issue":"4","key":"7350_CR50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/mus.23951","volume":"49","author":"F Sun","year":"2014","unstructured":"Sun F, Ladha SS, Yang L, Liu Q, Shi SX, Su N, Bomprezzi R, Shi FD (2014) Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis. Muscle Nerve 49(4):487\u2013494. https:\/\/doi.org\/10.1002\/mus.23951","journal-title":"Muscle Nerve"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07350-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07350-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07350-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:45:36Z","timestamp":1782899136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07350-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":50,"alternative-id":["7350"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07350-w","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures and protocols utilized in this study were approved by the Clinical Research Ethics Committee of Bursa Uludag University, in accordance with guidelines (Decision Number: 2022-16\/50).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have reviewed the manuscript and agreed to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent forms were obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}